![](/img/cover-not-exists.png)
Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma
Anforth, R.M., Blumetti, T.C.M.P., Kefford, R.F., Sharma, R., Scolyer, R.A., Kossard, S., Long, G.V., Fernandez-Peñas, P.Volume:
167
Language:
english
Journal:
British Journal of Dermatology
DOI:
10.1111/j.1365-2133.2012.11155.x
Date:
November, 2012
File:
PDF, 564 KB
english, 2012